Научно-практический журнал
[About us] Journal 'Cytokines & Inflammation'

197376, Санкт-Петербург, ул. Акад. Павлова, д. 12,
Институт экспериментальной медицины РАМН
Тел.: (812) 543 52 14, +7 921 984 11 30, +7 921 909 55 49
Факс: (812) 543 52 14
E-mail:
Web: www.cytokines.ru


  


Year 2018
1-4 issues

About journal

Current year
Archive

Columns
Subscription

Rules for authors

Contact us

Search

Site map

Our partners:
Русский языкEnglish language
Site map Contact us

Contents | Next article | Previous article

Journal 'Cytokines & inflammation', 2011, No. 3

Subscribe for 2019 year

Order this issue

Order PDF of this article

Original Articles

Number 3'2011

Features of immune and cytokine status in patients with atherosclerosis of lower extremities

T.S. Zaporozhets, K.V. Maystrovskiy, V.G. Rapovka, L.A. Ivanushko A.K. Gazha, T.P. Smolina

The relationship of cytokine status and activation antigens of peripheral blood lymphocytes in patients with atherosclerosis of vessels of the lower extremities was examined. It is established that the development of atherosclerosis is associated with an increase in the absolute number of circulating lymphocytes, increased expression of IL-2 receptor (CD25), class II antigens of major histocompatibility complex (HLA-DR), apoptotic marker CD95/Fas on the surface of peripheral blood lymphocytes, increase in serum levels of proinflammatory cytokines (IL-6, IFNγ, IL-8), and decrease of IL-10 and IL-4. The dependence of quantitative parameters (ratio of lymphocyte subpopulations, expression of activation markers, and level of pro-inflammatory cytokines) on the severity of the main and associated diseases was shown. It is concluded that serum IFNγ and IL-8 and the level of expression of activation antigens CD25 and HLA-DR on circulating lymphocytes can be used as a marker of the progression of obliterative atherosclerosis of the lower extremities. (Cytokines and Inflammation. 2011. Vol. 10. № 3. P. 68–75.)

Keywords: atherosclerosis, activation antigens, cytokines, lymphocyte subpopulations.

Contents | Next article | Previous article


© 2007-2019 Cytokines and inflammation